Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.33 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.33 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | BRD4 | O60885 | 1/20 | 0.31 |
| ▸ | DAO | P14920 | 1/20 | 0.31 |
| ▸ | B3GNT2 | Q9NY97 | 1/20 | 0.30 |
| ▸ | MPO | P05164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7020008 | 1.00 | CYP1A2 (0.33) | CYP1A2CRBNTBXAS1MEN1KMT2A | |
| SCHEMBL7024907 | 0.88 | QPCT (0.33) | CYP1A2CRBNMPO | |
| SCHEMBL7024912 | 0.88 | QPCT (0.33) | CYP1A2CRBNMPO | |
| SCHEMBL7017549 | 0.75 | BRD4 (0.33) | BRD4 | |
| SCHEMBL7017554 | 0.75 | BRD4 (0.33) | BRD4 | |
| SCHEMBL7019026 | 0.75 | CYP1A2 (0.32) | CYP1A2CRBNMEN1KMT2A | |
| SCHEMBL7019031 | 0.75 | CYP1A2 (0.32) | CYP1A2CRBNMEN1KMT2A | |
| SCHEMBL7012482 | 0.74 | ADORA3 (0.33) | CYP1A2CRBNMEN1KMT2AMPO | |
| SCHEMBL7012478 | 0.74 | ADORA3 (0.33) | CYP1A2CRBNMEN1KMT2AMPO | |
| SCHEMBL7022854 | 0.73 | CYP1A2 (0.59) | CYP1A2MEN1KMT2AMPO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2003089416-A1 | SUBSTITUTED PYRIMIDINE-2,4(1H,3H)-DIONES FOR USE AS MATRIX METALLOPROTEINASE (MMP) INHIBITORS | IBFB GMBH (DE) | 2003-10-30 | — | — | WO | claimed |
| EP-1357114-A1 | Substituted pyrimidin-2,4(1H,3H)-diones as inhibitors of Matrix Metalloproteinases (MMP) | IBFB GmbH Privates Institut für biomedizinische Forschung und Beratung (DE) | 2003-10-29 | — | — | EP | claimed |
| WO-2003089416-A1 | SUBSTITUTED PYRIMIDINE-2,4(1H,3H)-DIONES FOR USE AS MATRIX METALLOPROTEINASE (MMP) INHIBITORS | IBFB GMBH (DE) | 2003-10-30 | — | — | WO | disclosed |
| EP-1357114-A1 | Substituted pyrimidin-2,4(1H,3H)-diones as inhibitors of Matrix Metalloproteinases (MMP) | IBFB GmbH Privates Institut für biomedizinische Forschung und Beratung (DE) | 2003-10-29 | — | — | EP | disclosed |